CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	$ (94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022		12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued		797,849
Net share settlement of stock options and restricted stock units	(2,375)	$ (2,375)
Net share settlement of stock options and restricted stock units (in shares)		(224,320)
Stock-based compensation expense	548	$ 548
Repurchase and retirement of common stock	$ (6,253)		(6,253)
Repurchase and retirement of common stock (in shares)	(479,966)	(479,966)
Net Income Loss	$ (7,855)		(7,855)
Balance, end of period at Apr. 30, 2022	$ 65,207	$ 174,045	(108,838)
Balance, end of period (in shares) at Apr. 30, 2022	12,727,615	12,727,615
Balance, beginning of period at Jan. 28, 2023	$ 29,773	$ 175,450	(145,677)
Balance, beginning of period (in shares) at Jan. 28, 2023	12,754,368	12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 0
Restricted stock issued		86,824
Net share settlement of stock options and restricted stock units	(76)	$ (76)
Net share settlement of stock options and restricted stock units (in shares)		(28,294)
Stock-based compensation expense	$ 490	$ 490
Repurchase and retirement of common stock (in shares)	0
Net Income Loss	$ (12,107)		(12,107)
Balance, end of period at Apr. 29, 2023	$ 18,080	$ 175,864	$ (157,784)
Balance, end of period (in shares) at Apr. 29, 2023	12,812,898	12,812,898